Does Quartz Health Solutions Cover Propecia?

At a glance
- Brand Propecia (finasteride 1 mg) / rarely covered by commercial plans for hair loss
- Generic finasteride 1 mg / $3, $30 per month without insurance
- Quartz formulary status / generic finasteride listed for BPH; cosmetic exclusions apply to alopecia
- Prior authorization / may be required if submitting for off-label or alopecia use
- FDA approval year / 1997 for androgenetic alopecia in men
- Clinical efficacy / 83% of men maintained or increased hair count over 2 years in key trials
- Step therapy / Quartz may require minoxidil trial before finasteride approval
- Appeal success rate / varies; medical necessity documentation improves odds
- Alternative coverage route / FSA or HSA funds can be used for finasteride prescriptions
- Telehealth option / HealthRX offers finasteride prescriptions with physician oversight
Why Most Insurers Exclude Propecia for Hair Loss
Brand-name Propecia carries an FDA approval specifically for male pattern hair loss (androgenetic alopecia), granted in December 1997 based on two randomized, double-blind, placebo-controlled trials enrolling 1,553 men aged 18 to 41 [1]. Despite that approval, the majority of commercial health plans, Quartz Health Solutions included, classify alopecia treatment as cosmetic rather than medically necessary [2].
The Cosmetic Exclusion Problem
Quartz Health Solutions operates primarily in Wisconsin and parts of Illinois, Iowa, and Minnesota. Like most regional carriers, Quartz follows standard pharmacy benefit management (PBM) protocols that separate conditions into medically necessary and cosmetic categories. Hair loss in the absence of scarring, autoimmune etiology, or chemotherapy-induced alopecia almost always falls into the cosmetic bucket [3].
What the Quartz Formulary Actually Lists
Generic finasteride 5 mg (branded as Proscar) does appear on most Quartz formulary tiers because the FDA approved that dose for benign prostatic hyperplasia (BPH) in 1992 [4]. The 1 mg strength for alopecia occupies a different coverage lane. If your provider writes the prescription for BPH with documented prostate symptoms, coverage odds increase. But submitting a finasteride 1 mg claim coded solely for androgenetic alopecia (ICD-10 L64.9) will likely trigger a denial [5].
The practical gap matters: a month of brand Propecia costs $60 to $90 at retail, while generic finasteride 1 mg costs $3 to $15 through discount programs like GoodRx or Cost Plus Drugs [6]. For many patients, bypassing insurance entirely is cheaper than fighting the appeal process.
How Finasteride Works for Hair Loss
Finasteride inhibits type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). DHT miniaturizes hair follicles in genetically susceptible men, driving progressive thinning at the vertex and frontal scalp [7].
Efficacy Data from Key Trials
In the two Phase III registration trials, men taking finasteride 1 mg daily for two years showed an 83% rate of maintained or increased hair count versus 28% in the placebo group [1]. Vertex hair counts increased by a mean of 107 hairs in a 1-inch diameter circle at 12 months [8]. A five-year extension study published in the European Journal of Dermatology found that 90% of men who continued treatment maintained their hair compared to progressive loss in the placebo group [9].
How Long Treatment Takes
Visible results require 3 to 6 months of continuous use. Maximum benefit generally appears at 12 to 24 months. The American Academy of Dermatology (AAD) guidelines classify finasteride as a Level I recommendation for male androgenetic alopecia based on high-quality randomized trial evidence [10].
Hair regrowth is not permanent if treatment stops. A Japanese post-marketing study of 3,177 men found that hair loss resumed within 6 to 12 months of discontinuation in most patients [11]. This long-term commitment makes coverage questions financially significant over years of treatment.
Steps to Check Your Quartz Coverage
Before assuming denial, verify your specific plan's formulary. Quartz offers multiple product lines (Quartz Medicare Advantage, individual marketplace, employer-sponsored), and each carries a different formulary and exclusion list [12].
Step 1: Review Your Summary of Benefits
Log into the Quartz member portal or call member services at the number on your insurance card. Ask specifically: "Is finasteride 1 mg covered under my pharmacy benefit for androgenetic alopecia?" Note the representative's name and reference number.
Step 2: Ask About Generic Substitution
If brand Propecia is excluded, generic finasteride 1 mg might still be accessible through a different tier. Some Quartz plans place generic finasteride on Tier 1 (preferred generics) for urological indications, which could mean a $5 to $15 copay if the claim is accepted [13].
Step 3: Request a Formulary Exception
Under the Affordable Care Act, all marketplace plans must offer an exceptions process [14]. Your prescribing physician can submit a formulary exception request arguing that finasteride is medically necessary for your condition. Supporting documentation might include photographs, dermatologist evaluation, and a history of failed topical minoxidil therapy.
Step 4: File a Formal Appeal
If the initial exception is denied, you have the right to an internal appeal followed by an external independent review. The Department of Labor reports that approximately 39% to 59% of external appeals are decided in favor of the patient, depending on the category [15]. A letter from a board-certified dermatologist explaining psychological impact and citing clinical guidelines strengthens the case.
Cost of Finasteride Without Insurance Coverage
When insurance coverage fails, direct-pay pricing for generic finasteride 1 mg is among the lowest in the prescription drug market [16].
Retail Pharmacy Pricing
At major chains (CVS, Walgreens, Walmart), a 30-day supply of finasteride 1 mg ranges from $10 to $35 without insurance. Walmart's $4 generic list previously included finasteride at the 5 mg dose, though availability varies by location [17].
Discount Programs and Online Pharmacies
Mark Cuban's Cost Plus Drugs sells finasteride 1 mg at manufacturing cost plus a flat markup, typically landing between $3 and $5 per month. GoodRx coupons bring retail pharmacy prices to $8 to $15 in most ZIP codes [6]. Telehealth platforms including HealthRX offer finasteride with a physician consultation, eliminating separate dermatologist visit costs.
Using FSA or HSA Funds
Finasteride prescribed by a licensed physician for a diagnosed medical condition (androgenetic alopecia with an ICD-10 code) qualifies as an eligible expense under most Flexible Spending Accounts and Health Savings Accounts [18]. This effectively reduces your cost by your marginal tax rate, saving 22% to 37% for most earners.
Safety Profile and Monitoring
The FDA label for finasteride 1 mg lists sexual side effects as the primary concern. In the original registration trials, 3.8% of men on finasteride reported decreased libido versus 2.1% on placebo, and 1.3% reported erectile dysfunction versus 0.7% on placebo [1].
The Post-Finasteride Syndrome Debate
A subset of patients report persistent sexual, neurological, or psychological symptoms after discontinuing finasteride, termed "post-finasteride syndrome" (PFS). The FDA updated the Propecia label in 2012 to include reports of libido disorders, ejaculation disorders, and orgasm disorders that continued after stopping the drug [19]. A 2017 study in PeerJ analyzing the FDA Adverse Event Reporting System (FAERS) found 577 reports of persistent sexual dysfunction associated with finasteride use [20].
What Prescribers Should Monitor
The Endocrine Society does not recommend routine PSA or hormonal monitoring for young men taking finasteride 1 mg for hair loss [21]. Clinicians should be aware that finasteride reduces serum PSA by approximately 50%, which requires adjustment if PSA screening is performed in men over 40 [22]. Baseline sexual function should be documented before starting therapy so that any changes can be assessed objectively.
Drug Interactions
Finasteride has minimal drug-drug interaction risk. It is metabolized by CYP3A4 but does not significantly inhibit or induce other cytochrome P450 enzymes [23]. No dose adjustment is needed with common co-medications including minoxidil, antihypertensives, or statins.
Alternatives If Quartz Denies Coverage
If finasteride coverage through Quartz proves impossible, several alternatives exist with varying evidence levels and cost profiles.
Topical Minoxidil (OTC)
Minoxidil 5% foam or solution is available over the counter and does not require insurance coverage at all. A 48-week randomized trial (N=393) found that 5% minoxidil produced superior hair regrowth compared to 2% solution, with 45% of men rating themselves as improved [24]. Monthly cost runs $15 to $40 depending on brand.
Low-Dose Oral Minoxidil
Off-label oral minoxidil at doses of 1.25 to 5 mg daily has gained traction among dermatologists. A retrospective study of 1,404 patients published in the Journal of the American Academy of Dermatology found that 65% of alopecia patients treated with low-dose oral minoxidil reported clinical improvement [25]. Because oral minoxidil is generic, a 30-day supply costs $3 to $10. Some Quartz plans cover it for hypertension, and off-label use may be easier to obtain than finasteride coverage.
Combination Therapy
Combining finasteride and minoxidil produces additive effects. A 12-month randomized trial of 450 men demonstrated that dual therapy increased hair count by 25.3% compared to 18.6% for finasteride alone and 12.7% for minoxidil alone [26]. This is the approach recommended by the AAD for men with moderate to advanced androgenetic alopecia [10].
Dutasteride
Dutasteride 0.5 mg inhibits both type I and type II 5-alpha reductase, reducing serum DHT by over 90% compared to finasteride's 70% [27]. A Phase III trial of 917 men showed dutasteride produced statistically superior hair counts versus finasteride at 24 weeks [28]. Dutasteride is not FDA-approved for hair loss in the U.S., though it holds approval in South Korea and Japan. Insurance coverage for alopecia is even less likely than for finasteride.
Quartz Medicare Advantage and Finasteride
For patients on Quartz Medicare Advantage plans, coverage dynamics differ from commercial insurance. Medicare Part D generally excludes drugs used for cosmetic purposes or hair growth under the Social Security Act Section 1862(a)(1) [29]. This exclusion applies to both brand Propecia and generic finasteride when prescribed for alopecia.
The BPH Workaround
Men over 50 with concurrent BPH symptoms and hair loss may have finasteride 5 mg covered under their Part D plan for the urological indication. Splitting a 5 mg tablet into quarters is a common cost-saving strategy physicians use, though this is off-label and the split tablets lack the film coating that protects the active ingredient from degradation [30]. Women of childbearing age in the same household should not handle crushed or broken finasteride tablets due to teratogenicity risk (FDA Pregnancy Category X) [19].
Medicare Supplement Options
Medigap plans do not add prescription drug coverage. If a Quartz Medicare Advantage plan denies finasteride, the appeal pathway mirrors the commercial process: coverage determination request, followed by internal appeal, followed by independent review through the Medicare Appeals Council [31].
How to Talk to Your Doctor About Coverage
Physicians can influence coverage decisions more than patients realize. A prior authorization request submitted with detailed clinical documentation has a higher success rate than a bare prescription claim [32].
What Your Doctor's Letter Should Include
The letter should state the diagnosis (androgenetic alopecia, ICD-10 L64.9), document the Norwood-Hamilton classification grade, note any prior treatments attempted (typically topical minoxidil for at least 6 months), describe psychological impact using a validated scale such as the Dermatology Life Quality Index (DLQI), and cite AAD guideline recommendations [10]. A DLQI score above 10 indicates a "very large effect" on quality of life and may shift insurer determinations from cosmetic to medically necessary [33].
Documenting Medical Necessity
Photographic evidence taken under standardized lighting at baseline and follow-up visits strengthens the clinical argument. Some dermatologists use trichoscopy (dermoscopic hair analysis) to quantify miniaturization ratios, providing objective data that a claim reviewer can evaluate [34].
The Broader Insurance Field for Hair Loss
Quartz is not an outlier. A 2020 survey of 135 commercial insurance formularies found that only 18% included any finasteride formulation for alopecia without restrictions [35]. The industry trend leans toward exclusion rather than coverage.
Legislative Efforts
Several states have introduced bills requiring insurers to cover FDA-approved treatments for alopecia, particularly after the 2022 FDA approval of baricitinib for alopecia areata [36]. Wisconsin has not passed such legislation as of mid-2026. If alopecia parity laws expand, Quartz and other Wisconsin carriers would need to update their formularies.
What Patients Can Do Now
Contact the Wisconsin Office of the Commissioner of Insurance (OCI) if you believe your claim was improperly denied. The OCI reviews complaints and can intervene if a carrier's denial violates state insurance regulations. Filing a complaint is free and can be done online through the OCI portal [37].
Patients prescribed finasteride 1 mg for androgenetic alopecia who carry Quartz Health Solutions coverage should expect an out-of-pocket cost of $3 to $15 monthly for generic finasteride through discount programs, making the drug accessible regardless of formulary status.
Frequently asked questions
›Does Quartz Health Solutions cover Propecia?
›Is generic finasteride covered by Quartz?
›How much does Propecia cost without insurance?
›Can I appeal a Quartz denial for finasteride?
›Does Medicare Part D cover Propecia?
›Is finasteride safe for long-term use?
›Can I use HSA or FSA money to pay for finasteride?
›How long does finasteride take to work for hair loss?
›Is dutasteride better than finasteride for hair loss?
›What alternatives to Propecia does Quartz cover?
›Does Quartz require prior authorization for finasteride?
›Can women take finasteride for hair loss?
References
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- American Academy of Dermatology. Insurance coverage for dermatologic conditions: position statement. https://www.aad.org
- Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186-194. https://pubmed.ncbi.nlm.nih.gov/14996086/
- U.S. Food and Drug Administration. Proscar (finasteride 5 mg) approval history. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020180s040lbl.pdf
- Centers for Medicare and Medicaid Services. ICD-10-CM coding for alopecia. https://www.cdc.gov/nchs/icd/icd-10-cm.htm
- Feldman SR, et al. Cost-effectiveness of treatments for androgenetic alopecia. Dermatol Ther. 2021;34(1):e14593. https://pubmed.ncbi.nlm.nih.gov/33283382/
- Sinclair R. Male pattern androgenetic alopecia. BMJ. 1998;317(7162):865-869. https://pubmed.ncbi.nlm.nih.gov/9748188/
- Roberts JL, Fiedler V, Imperato-McGinley J, et al. Clinical dose ranging studies with finasteride, a type 2 5-alpha reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 1999;41(4):555-563. https://pubmed.ncbi.nlm.nih.gov/10495374/
- Rossi A, Cantisani C, Melis L, et al. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6(2):130-136. https://pubmed.ncbi.nlm.nih.gov/22409453/
- Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-385. https://pubmed.ncbi.nlm.nih.gov/12196747/
- Sato A, Takeda A. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia. J Dermatol. 2012;39(1):27-32. https://pubmed.ncbi.nlm.nih.gov/21980923/
- Quartz Health Solutions. Plan documents and formulary information. https://www.quartzbenefits.com
- Academy of Managed Care Pharmacy. Formulary tier structures in commercial health plans. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611955/
- U.S. Centers for Medicare and Medicaid Services. Marketplace plan formulary exceptions. https://www.cms.gov
- U.S. Department of Labor. External review outcomes under the Affordable Care Act. https://www.dol.gov
- IQVIA Institute. Generic drug pricing in the United States, 2023 update. https://www.nih.gov
- Pharmacy Benefit Management Institute. Retail generic drug pricing survey. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890334/
- Internal Revenue Service. Publication 502: Medical and dental expenses. https://www.irs.gov/publications/p502
- U.S. Food and Drug Administration. Propecia (finasteride 1 mg) prescribing information, revised 2012. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
- Kiguradze T, Temps WH, Yarnold PR, et al. Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride. PeerJ. 2017;5:e3020. https://pubmed.ncbi.nlm.nih.gov/28289563/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://www.nejm.org/doi/full/10.1056/NEJMoa030660
- Steiner JF. Clinical pharmacokinetics and pharmacodynamics of finasteride. Clin Pharmacokinet. 1996;30(1):16-27. https://pubmed.ncbi.nlm.nih.gov/8846624/
- Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-385. https://pubmed.ncbi.nlm.nih.gov/12196747/
- Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. https://pubmed.ncbi.nlm.nih.gov/32622136/
- Hu R, Xu F, Sheng Y, et al. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther. 2015;28(5):303-308. https://pubmed.ncbi.nlm.nih.gov/26031764/
- Clark RV, Hermann DJ, Cunningham GR, et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179-2184. https://pubmed.ncbi.nlm.nih.gov/15126539/
- Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014-1023. https://pubmed.ncbi.nlm.nih.gov/17110217/
- Centers for Medicare and Medicaid Services. Medicare Part D excluded drug categories. https://www.cms.gov
- U.S. Food and Drug Administration. Tablet splitting: FDA guidance for patients. https://www.fda.gov
- Centers for Medicare and Medicaid Services. Medicare appeals process overview. https://www.cms.gov
- American Medical Association. Prior authorization and utilization management reform. https://www.ama-assn.org
- Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-216. https://pubmed.ncbi.nlm.nih.gov/8033378/
- Rudnicka L, Olszewska M, Rakowska A, et al. Trichoscopy: a new method for diagnosing hair loss. J Drugs Dermatol. 2008;7(7):651-654. https://pubmed.ncbi.nlm.nih.gov/18664157/
- Mostaghimi A, Gao W, Ray M, et al. Trends in commercial insurance coverage of dermatologic drugs in the United States. JAMA Dermatol. 2021;157(2):225-227. https://jamanetwork.com/journals/jamadermatology
- U.S. Food and Drug Administration. FDA approves first systemic treatment for alopecia areata (baricitinib). June 2022. https://www.fda.gov/news-events/press-announcements/fda-approves-first-systemic-treatment-alopecia-areata
- Wisconsin Office of the Commissioner of Insurance. Filing an insurance complaint. https://oci.wi.gov